Similarly, it was recently shown that intestinal inflammation, colon cancer development, and tumor angiogenesis were decreased in Gpr4‐deficient animals compared to wild‐type (WT) controls [34]. This evidence concerns the gene GPR4 and malignant colon neoplasm.